These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34946316)

  • 1. A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.
    Cannizzaro DN; Naughton LF; Freeman MZ; Martin L; Bennett CL; Bove C
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946316
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network.
    Kaur K; Fayad R; Saxena A; Frizzell N; Chanda A; Das S; Chatterjee S; Hegde S; Baliga MS; Ponemone V; Rorro M; Greene J; Elraheb Y; Redd AJ; Bian J; Restaino J; Norris LB; Qureshi ZP; Love BL; Brookstaver B; Georgantopoulos P; Sartor O; Raisch DW; Rao G; Lu K; Ray P; Hrusheshky W; Schulz R; Ablin R; Noxon V; Bennett CL;
    J Community Support Oncol; 2016 Feb; 14(2):54-65. PubMed ID: 26955658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate use of fluoroquinolones in children.
    Principi N; Esposito S
    Int J Antimicrob Agents; 2015 Apr; 45(4):341-6. PubMed ID: 25726705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials.
    Tandan M; Cormican M; Vellinga A
    Int J Antimicrob Agents; 2018 Nov; 52(5):529-540. PubMed ID: 29702230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profiles.
    Sousa J; Alves G; Fortuna A; Falcão A
    Curr Drug Saf; 2014; 9(2):89-105. PubMed ID: 24410307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites.
    Lewis G; Juhasz A; Smith E
    Environ Sci Pollut Res Int; 2011 Aug; 19(7):2795-801. PubMed ID: 22311580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders.
    Jones MP; Shah A; Walker MM; Koloski NA; Holtmann G; Talley NJ
    United European Gastroenterol J; 2021 Nov; 9(9):1074-1080. PubMed ID: 34653313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones: old drugs, putative new toxicities.
    Bove C; Baldock RA; Champigneulle O; Martin L; Bennett CL
    Expert Opin Drug Saf; 2022 Nov; 21(11):1365-1378. PubMed ID: 36384376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Policy-driven revolution of prescription record in outpatient use of fluoroquinolones.
    Kuo SC; Shih SM; Lauderdale TY; Chang IS; Chen YC; Hsiung CA; Chang SC
    J Microbiol Immunol Infect; 2020 Feb; 53(1):133-140. PubMed ID: 29886011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
    Cowart K; Worley M; Rouby NE; Sando K
    Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
    [No Abstract]   [Full Text] [Related]  

  • 11. The frequency of and factors affecting functional gastrointestinal disorders in infants that presented to tertiary care hospitals.
    Beser OF; Cullu Cokugras F; Dogan G; Akgun O; Elevli M; Yilmazbas P; Ocal M; Bayrak NA; Sezer Yamanel RG; Bozaykut A; Celtik C; Polat E; Gerenli N; Bozlak S; Ayyildiz Civan H; Ozkul Saglam N; Hatipoglu SS; Özgürhan G; Sunnetci Silistre E; Solmaz B; Kutluk G; Genc HS; Onal H; Usta AM; Urganci N; Sahin A; Cam S; Yildirim S; Yildirim A; Vandenplas Y
    Eur J Pediatr; 2021 Aug; 180(8):2443-2452. PubMed ID: 33811535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Concerns Surrounding Quinolone Use in Children.
    Patel K; Goldman JL
    J Clin Pharmacol; 2016 Sep; 56(9):1060-75. PubMed ID: 26865283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders.
    Paula H; Grover M; Halder SL; Locke GR; Schleck CD; Zinsmeister AR; Talley NJ
    Neurogastroenterol Motil; 2015 Nov; 27(11):1580-6. PubMed ID: 26303310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in pediatric patients with functional and organic gastrointestinal diseases in comparison to healthy controls.
    Varni JW; Bendo CB; Denham J; Shulman RJ; Self MM; Neigut DA; Nurko S; Patel AS; Franciosi JP; Saps M; Yeckes A; Langseder A; Saeed S; Pohl JF
    Qual Life Res; 2015 Feb; 24(2):363-78. PubMed ID: 25148757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.
    Hsu SC; Chang SS; Lee MG; Lee SH; Tsai YW; Lin SC; Chen ST; Weng YC; Porta L; Wu JY; Lee CC
    PLoS One; 2017; 12(9):e0183813. PubMed ID: 28873440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.
    Arabyat RM; Raisch DW; McKoy JM; Bennett CL
    Expert Opin Drug Saf; 2015; 14(11):1653-60. PubMed ID: 26393387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.
    Jones SC; Sorbello A; Boucher RM
    Drug Saf; 2011 Oct; 34(10):839-47. PubMed ID: 21879778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.
    de Lastours V; Chau F; Roy C; Larroque B; Fantin B
    J Antimicrob Chemother; 2014 Dec; 69(12):3393-400. PubMed ID: 25063781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
    Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.
    de Lastours V; Fantin B
    Future Microbiol; 2015; 10(7):1241-55. PubMed ID: 26119580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.